GlassScriptPhysician profile
Matthew Blanchard
NPI 1043741705
$10,481.59
in general payments reported to CMS, 2019-2025
16 companies · $1,682 in 2025
The $1,682 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,133 · 2022: $4,372 · 2023: $2,004 · 2024: $291 · 2025: $1,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450 · Travel and Lodging: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.46 |
| Travel and Lodging | $1,526.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,850.29 | 2022-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $2,351.32 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,644.59 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Pacira Pharmaceuticals Incorporated | $1,269.86 | 2025 | Iovera |
| Relievant Medsystems, INC. | $1,217.82 | 2022-2023 | Intracept |
| Curonix LLC | $458.07 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $222.13 | 2023-2024 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $160.48 | 2025 | Prospera |
| Nalu Medical, INC. | $87.42 | 2022-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $70.65 | 2022-2023 | Sprint Pns System |
| Mml US, INC. | $47.30 | 2023 | Reactiv8 |
| Merck Sharp & Dohme LLC | $29.16 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.72 | 2023 | Belbuca |
| Vertos Medical, INC. | $20.65 | 2023 | Mild Device Kit |
| Nevro Corp. | $17.72 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Blanchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.